Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. IK Investment Partners to acquire A-Katsastus Group’s operations in Sweden, Poland and the Baltics
Mandate

IK Investment Partners to acquire A-Katsastus Group’s operations in Sweden, Poland and the Baltics

June 04, 2018 Banking and Finance Automotive, Mobility and Electrification

Vinge has advised IK Small Cap II Fund in connection with entering into an agreement to acquire Carspect AB, SIA Scantest, Autotest Polska Sp. Z.o.o and A-Ülevaatus OÜ (“the Group”), from A-Katsastus Group Oy, a leading provider of vehicle inspection services in Northern Europe.

Completion of the transaction is subject to customary conditions.

Vinge’s team consisted of, among others, partner Jonas Bergström together with associates Johanna Wiberg, Michaela Cronemyrand Karolina Cohrs (M&A), partner Louise Brorson Salomon together with associate Lionardo Ojeda (financing).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026